Enhancing the efficacy and ease of application of existing endemic livestock disease vaccines via novel adjuvants and delivery systems

点击翻译按钮获取中文摘要

Endemic infectious diseases of livestock cause major financial losses and threaten food security, animal welfare, and public health. Vaccination is a highly cost-effective tool to help prevent, control, and eradicate diseases. However, many vaccines currently used to prevent and control endemic livestock diseases (ELD) are suboptimal. While they may help protect animals from suffering disease, they may not effectively control the disease-causing microbe (pathogen). This allows pathogens to be transmitted to other animals and potentially to mutate as they replicate, which makes them more resistant to vaccines. In addition to these inherent shortcomings, there are practical issues of storage and administration of vaccines on-farm that require improvement to optimise the benefits to users and animals from vaccination. This project aims to take advantage of recent advances in vaccine formulation and delivery to devise strategies that could make ELD vaccines more effective and easier to administer. We will use vaccines for control of the porcine reproductive and respiratory syndrome virus (PRRSV) as a test case. PRRSV is responsible for one of the most economically important diseases affecting the global pig industry and is a priority disease for the UK pig sector. Vaccination is a cornerstone of PRRS control, but improved vaccines are urgently required. The project is a collaboration between leading UK veterinary bioscience, social science, and stakeholders. Using a co-design and participatory approach, we will work with vaccine companies and selected producers, their veterinarians, and wider stakeholders to ensure that the research addresses their concerns and meets their needs with respect to on-farm delivery and use of vaccines to support a drive for improvement. By taking soundings from stakeholders, we will seek to understand, and therefore take into account, their concerns and needs as regards on-farm vaccine use. We will explore issues around the acceptance of new vaccines and delivery devices. We will then conduct a 'proof-of-concept' study to test whether new formulations of an existing PRRSV vaccine, delivered by innovative devices, provides enhanced protection, whilst being simple and practical to administer. Finally, we will take our findings back to producers via virtual workshops to obtain their feedback, which will help shape the future research and development of the approaches. This project will help deliver improved vaccines and their adoption, which will aid the prevention and control of ELD. Consequently, this project should lead to enhanced livestock health, welfare, and productivity, and reduced antimicrobial use. Whilst the most immediate benefit will likely be in the control of PRRSV, this project has the potential to have a wide impact by informing efforts to develop improved vaccine/formulations for other diseases of both livestock and humans.